Palisade Bio, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Carlsbad, CA
PALI chart
What traders are saying about $PALI
Latest postsPalisade Bio, Inc. news
- Palisade Bio Inc. (PALI) Misses Q3 EPS by 1c
StreetInsider ·
- Palisade Bio, Inc. Stock 12‑Month Price Target Cut to $9.18, Implies 713% Upside
TradingView ·
- Palisade Bio (PALI) Reports Q3 Earnings Miss, Market Pricing Reflects Growth Uncertainty
GuruFocus ·
- Palisade Bio Inc reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Palisade Bio doses first patient in ulcerative colitis trial
Investing.com ·
- Palisade Bio Q3 loss widens on higher R&D costs
TradingView ·
- PALI: Palisade Bio Inc. filed SEC Form 8-K: Results of Operations...
Quantisnow ·
- Palisade Bio Reports $14.6 Million Q3 Net Loss and Advances PALI-2108 Trials
TradingView ·
- Palisade Bio Reports Third Quarter 2026 Financial Results and Advances PALI-2108 Phase 2 Clinical Development Programs
Yahoo Finance ·
- Palisade Bio Reports Third Quarter 2026 Financial Results
GlobeNewswire ·
- Palisade Bio Reports $14.6 Million Third-Quarter Loss as PALI-2108 Trial Advances
Quiver Quantitative ·
- A trial for ulcerative colitis is underway; Palisade Bio expects results by the end of 2027.
Stock Titan ·
Palisade Bio, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | $0 | $250,000 | $0 |
| Net income | -$16.8M | -$14.4M | -$12.3M | -$14.3M |
| Diluted EPS | $-0.30 | $-10.19 | $-27.01 | $-16.53 |
| Total assets (year end) | $134.3M | $10.9M | $14.1M | $15.8M |
| Cash and equivalents (year end) | $133.4M | $9.8M | $12.4M | $12.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Palisade Bio, Inc.
- Ticker
- PALI (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Carlsbad, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1357459
- Former names
- PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
Frequently asked questions
What exchange is Palisade Bio, Inc. listed on?
Palisade Bio, Inc. trades on the Nasdaq under the ticker symbol PALI.
What industry is Palisade Bio, Inc. in?
Palisade Bio, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Palisade Bio, Inc. headquartered?
Palisade Bio, Inc.'s business address on file with the SEC is in Carlsbad, CA.
When does Palisade Bio, Inc.'s fiscal year end?
Palisade Bio, Inc.'s fiscal year ends on December 31.
How much revenue did Palisade Bio, Inc. report?
Palisade Bio, Inc. reported $0 in revenue for calendar year 2024, according to its SEC filings.